Your browser doesn't support javascript. This means that the content or functionality of our website will be limited or unavailable. If you need more information about Vinnova, please contact us.

Creation of an IP strategy for an innovative stem cell company.

Reference number
Coordinator NEXTCELL PHARMA AB - Karolinska Institutet Science Park
Funding from Vinnova SEK 100 000
Project duration April 2019 - August 2019
Status Completed

Purpose and goal

The objective of this project was to create and define a IP-strategy. We have done so by first analyzing the current situation, and after that writing recommendations on how we can improve this situation. on top of that we have been able to create a long term practical IP approach which we will implement in our daily processes.

Expected results and effects

The concrete outcomes are written in a IP-strategy document. This document is an analysis of our current situation, with recommendations for improvement and a guidance document with recommendations to manage our IP-strategy in the future. Generally we can say that this project now enables us to better manage all IP related issues.

Planned approach and implementation

The implementation is basically immediately, after receiving the recommendations and strategy guidance we are now in the process of building this into our company processes.

The project description has been provided by the project members themselves and the text has not been looked at by our editors.

Last updated 21 March 2019

Reference number 2018-04952

Page statistics